Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
ENROLLING BY INVITATION
NCT06914661
Efficacy and Safety of DS8201 in Metastatic Breast Cancer's Treatment
Sponsor: The First Hospital of Jilin University
View on ClinicalTrials.gov
Summary
This study analyzes the use of DS8201 in the treatment of metastatic breast cancer in the real world by analysis, exploring whether there are differences in effectiveness and safety between real-world conditions and clinical trials.
Official title: Multicenter Real-world Study on the Efficacy and Safety of DS8201 in the Treatment of Metastatic Breast Cancer
Key Details
Gender
All
Age Range
18 Years - 100 Years
Study Type
OBSERVATIONAL
Enrollment
200
Start Date
2025-05-25
Completion Date
2025-10-30
Last Updated
2025-07-08
Healthy Volunteers
No
Locations (1)
The First Hospital of Jilin University
Changchun, Jilin, China